Inventor
STOVER DAVID
US13 patents
⚠️ This page may combine multiple inventors who share the name “STOVER DAVID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NAMMI THERAPEUTICS INC
8 patentsUS11896646B2Feb 13, 2024
Formulated and/or co-formulated liposome compositions containing toll-like receptor (“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof
NAMMI THERAPEUTICS INC1 citations70
US11744874B2Sep 5, 2023
Formulated and/or co-formulated liposome compositions containing toll-like receptor (“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof
NAMMI THERAPEUTICS INC1 citations70
US11679141B2Jun 20, 2023
Formulated and/or co-formulated liposome compositions containing toll-like receptor (“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof
NAMMI THERAPEUTICS INC1 citations70
US12311010B2May 27, 2025
Formulated and/or co-formulated liposome compositions containing toll-like receptor(“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof
NAMMI THERAPEUTICS INC0 citations59
US12286403B2Apr 29, 2025
Formulated and/or co-formulated liposome compositions containing IDO antagonist prodrugs useful in the treatment of cancer and methods thereof
NAMMI THERAPEUTICS INC0 citations59
US12059470B2Aug 13, 2024
Formulated and/or co-formulated liposome compositions containing PD-1 antagonist prodrugs useful in the treatment of cancer and methods thereof
NAMMI THERAPEUTICS INC0 citations59
US11833209B2Dec 5, 2023
Formulated and/or co-formulated liposome compositions containing PD-1 antagonist prodrugs useful in the treatment of cancer and methods thereof
NAMMI THERAPEUTICS INC0 citations59
US11801304B2Oct 31, 2023
Formulated and/or co-formulated liposome compositions containing TFGB antagonist prodrugs useful in the treatment of cancer and methods thereof
NAMMI THERAPEUTICS INC1 citations59
QWIXEL THERAPEUTICS LLC
3 patentsUS12162958B2Dec 10, 2024
Fusion protein composition(s) comprising masked type i interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereof
QWIXEL THERAPEUTICS LLC1 citations65
US11136353B2Oct 5, 2021
Fusion protein composition(s) comprising masked type I interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereof
QWIXEL THERAPEUTICS LLC3 citations65
US11795198B2Oct 24, 2023
Fusion protein composition(s) comprising masked type I interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereof
QWIXEL THERAPEUTICS LLC0 citations54